Santa Cruz Biotechnology, Inc. offers a broad range of gene silencers in the form of siRNAs, shRNA Plasmids and shRNA Lentiviral Particles. Pira gene silencers are available as Pira siRNA, Pira shRNA Plasmid, Pira shRNA Lentiviral Particles. Gene silencers are useful for gene studies in combination with antibodies used for protein detection.
R indicates a highly recommended product based on customer preference.
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
Pira1 siRNA (m) | sc-152271 | m | Gene Silencing | N/A | 0 | ||
Pira1 Plasmídeo shRNA (m) | sc-152271-SH | m | Gene Silencing | Puromycin | 0 | ||
Pira1 sarna (m) Partículas de lentivirus | sc-152271-V | m | Gene Silencing | Puromycin | 0 | ||
Pira1 (m)-PR | sc-152271-PR | m | Primer | N/A | 0 | ||
Pira2 siRNA (m) | sc-152273 | m | Gene Silencing | N/A | 0 | ||
Pira2 Plasmídeo shRNA (m) | sc-152273-SH | m | Gene Silencing | Puromycin | 0 | ||
Pira2 sarna (m) Partículas de lentivirus | sc-152273-V | m | Gene Silencing | Puromycin | 0 | ||
Pira2 (m)-PR | sc-152273-PR | m | Primer | N/A | 0 | ||
Pira3 siRNA (m) | sc-152274 | m | Gene Silencing | N/A | 0 | ||
Pira3 Plasmídeo shRNA (m) | sc-152274-SH | m | Gene Silencing | Puromycin | 0 | ||
Pira3 sarna (m) Partículas de lentivirus | sc-152274-V | m | Gene Silencing | Puromycin | 0 | ||
Pira3 (m)-PR | sc-152274-PR | m | Primer | N/A | 0 | ||
Pira4 siRNA (m) | sc-152275 | m | Gene Silencing | N/A | 0 | ||
Pira4 Plasmídeo shRNA (m) | sc-152275-SH | m | Gene Silencing | Puromycin | 0 | ||
Pira4 sarna (m) Partículas de lentivirus | sc-152275-V | m | Gene Silencing | Puromycin | 0 | ||
Pira4 (m)-PR | sc-152275-PR | m | Primer | N/A | 0 | ||
Pira11 siRNA (m) | sc-152272 | m | Gene Silencing | N/A | 0 | ||
Pira11 Plasmídeo shRNA (m) | sc-152272-SH | m | Gene Silencing | Puromycin | 0 | ||
Pira11 sarna (m) Partículas de lentivirus | sc-152272-V | m | Gene Silencing | Puromycin | 0 | ||
Pira11 (m)-PR | sc-152272-PR | m | Primer | N/A | 0 |